SURG(SURG)
SURG
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $65M | $80M |
| Low | $65M | $80M |
| High | $65M | $80M |
| EBITDA Avg | $-15M | $-19M |
| Low | $-15M | $-19M |
| High | $-15M | $-19M |
| EBIT Avg | $-16M | $-20M |
| Low | $-16M | $-20M |
| High | $-16M | $-20M |
| Net Income Avg | $-14M | $1M |
| Low | $-14M | $1M |
| High | $-14M | $1M |
| EPS Avg | $-0.70 | $0.05 |
| Low | $-0.70 | $0.05 |
| High | $-0.70 | $0.05 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 |
|---|---|---|---|---|---|---|---|
| Revenue Avg | $14M | $19M | $17M | $19M | $17M | $23M | $21M |
| Low | $14M | $19M | $17M | $19M | $17M | $23M | $21M |
| High | $14M | $19M | $17M | $19M | $17M | $23M | $21M |
| EBITDA Avg | $-3M | $-4M | $-4M | $-5M | $-4M | $-6M | $-5M |
| Low | $-3M | $-4M | $-4M | $-5M | $-4M | $-6M | $-5M |
| High | $-3M | $-4M | $-4M | $-5M | $-4M | $-6M | $-5M |
| EBIT Avg | $-3M | $-5M | $-4M | $-5M | $-4M | $-6M | $-5M |
| Low | $-3M | $-5M | $-4M | $-5M | $-4M | $-6M | $-5M |
| High | $-3M | $-5M | $-4M | $-5M | $-4M | $-6M | $-5M |
| Net Income Avg | $-3M | $-2M | $-474,075 | $-237,037 | $-711,113 | $1M | $711,113 |
| Low | $-3M | $-2M | $-474,075 | $-237,037 | $-711,113 | $1M | $711,113 |
| High | $-3M | $-2M | $-474,075 | $-237,037 | $-711,113 | $1M | $711,113 |
| EPS Avg | $-0.11 | $-0.08 | $-0.02 | $-0.01 | $-0.03 | $0.06 | $0.03 |
| Low | $-0.11 | $-0.08 | $-0.02 | $-0.01 | $-0.03 | $0.06 | $0.03 |
| High | $-0.11 | $-0.08 | $-0.02 | $-0.01 | $-0.03 | $0.06 | $0.03 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |